Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials

The number of immunotherapeutic clinical trials in type 1 diabetes currently being conducted is expanding, and thus there is a need for robust immune-monitoring assays which are capable of detecting and characterizing islet specific immune responses in peripheral blood. Islet- specific T cells can s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arif, Sefina, Domingo-Vila, Clara, Pollock, Emily, Christakou, Eleni, Williams, Evangelia, Tree, Timothy I. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240960/
https://www.ncbi.nlm.nih.gov/pubmed/37283770
http://dx.doi.org/10.3389/fimmu.2023.1183909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240960/
https://www.ncbi.nlm.nih.gov/pubmed/37283770
http://dx.doi.org/10.3389/fimmu.2023.1183909

Ejemplares similares